ACE2 and COVID-19: Chai et al., have analyzed the alteration of genetics, DNA methylation, and RNA expression for samples from COVID-19 patients, and found that during viral infection, angiotensin-converting enzyme 2 (ACE2) is identified as a membrane-binding receptor to the fusion and invasion process of the COVID-19 and host cells (Chai et al., 2020).